| Biological Sciences | 2021-2025 | 352 | US 76 | 99.63 |
| Molecular Biology | Lifetime | 739 | US 447 | 99.62 |
| Ophthalmology | Lifetime | 120 | US 72 | 99.31 |
| Cellular and Molecular Neuroscience | Lifetime | 431 | US 232 | 98.41 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 927 | US 498 | 97.43 |
| Cellular and Molecular Neuroscience | 2021-2025 | 10 | US 7 | 99.04 |
| Molecular Biology | 2021-2025 | 181 | US 48 | 99.27 |
| Ophthalmology | 2021-2025 | 63 | US 23 | 98.48 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 399 | US 147 | 92.06 |
| Retinal Development and Disorders | Lifetime | 8 | US 7 | 99.79 |
| Retinal Diseases and Treatments | Lifetime | 70 | US 41 | 99.63 |
| Pancreatitis Pathology and Treatment | Lifetime | 79 | US 37 | 99.41 |
| Photoreceptor and optogenetics research | Lifetime | 85 | US 49 | 99.42 |
| Neuroscience and Neural Engineering | Lifetime | 106 | US 58 | 99.39 |
| Gastrointestinal disorders and treatments | Lifetime | 191 | US 83 | 99.11 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 752 | US 330 | 98.34 |
| Retinal Imaging and Analysis | Lifetime | 284 | US 119 | 98.43 |
| Retinal and Optic Conditions | Lifetime | 262 | US 124 | 98.37 |
| Glaucoma and retinal disorders | Lifetime | 650 | US 275 | 98.36 |
| Retinal and Macular Surgery | Lifetime | 249 | US 114 | 97.72 |
| Pediatric Hepatobiliary Diseases and Treatments | Lifetime | 874 | US 302 | 95.88 |
| Connexins and lens biology | Lifetime | 429 | US 198 | 95.08 |
| Ocular Oncology and Treatments | Lifetime | 390 | US 208 | 94.59 |
| Ophthalmology and Visual Impairment Studies | Lifetime | 642 | US 242 | 95.92 |
| Ocular Diseases and Behçet’s Syndrome | Lifetime | 675 | US 267 | 95.49 |
| Drug-Induced Ocular Toxicity | Lifetime | 104 | US 58 | 93.02 |
| Optical Coherence Tomography Applications | Lifetime | 803 | US 295 | 93.48 |
| Retinopathy of Prematurity Studies | Lifetime | 522 | US 232 | 89.92 |
| Ocular Disorders and Treatments | Lifetime | 647 | US 268 | 83.52 |
| Retinal Development and Disorders | 2021-2025 | 1 | US 1 | 99.89 |
| Retinal Diseases and Treatments | 2021-2025 | 21 | US 8 | 99.53 |
| Photoreceptor and optogenetics research | 2021-2025 | 16 | US 2 | 98.65 |
| Neuroscience and Neural Engineering | 2021-2025 | 221 | US 44 | 94.99 |
| CRISPR and Genetic Engineering | 2021-2025 | 341 | US 105 | 94.07 |
| Ocular Diseases and Behçet’s Syndrome | 2021-2025 | 190 | US 41 | 92.96 |
| Retinal and Optic Conditions | 2021-2025 | 459 | US 120 | 91.35 |
| Virus-based gene therapy research | 2021-2025 | 690 | US 231 | 87.94 |
| Optical Coherence Tomography Applications | 2021-2025 | 303 | US 60 | 88.53 |
| Mitochondrial Function and Pathology | 2021-2025 | 901 | US 262 | 86.22 |
| Retinal Imaging and Analysis | 2021-2025 | 921 | US 226 | 88.44 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 173 | US 64 | 80.18 |
| Ophthalmology and Visual Impairment Studies | 2021-2025 | 783 | US 128 | 83.20 |
| Retinal and Macular Surgery | 2021-2025 | 491 | US 111 | 79.74 |
| Drug-Induced Ocular Toxicity | 2021-2025 | 92 | US 32 | 62.69 |
| Retinopathy of Prematurity Studies | 2021-2025 | 520 | US 163 | 61.57 |
| Connexins and lens biology | 2021-2025 | 646 | US 179 | 54.74 |
| Ocular Disorders and Treatments | 2021-2025 | 282 | US 43 | 55.38 |
| Spatial Cognition and Navigation | 2021-2025 | 471 | US 111 | 53.34 |
